PROCÉDÉ DE TRAITEMENT UTILISANT DES ANTICORPS ANTI-EGFR ET DES INHIBITEURS DE SRC, ET LEUR FORMULATIONS

• 收藏
• 分享

专利权人:

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.

发明人:

申请号：

EP08726810.8

公开号：

EP2134854B1

申请日:

2008.03.14

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination or simultaneously. The invention relates to treatment, prevention, or modulation of cancer, particularly EGFR-mediated disease, with one or more EGFR modulator and src inhibitor in combination. The invention further relates to the treatment of cancer with anti-EGFR antibodies and src inhibitors. Methods and compositions for treatment of cancer with the antibody anti-EGFR mAb806 in combination or series with a src inhibitor or src inhibitors are described.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/